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Nichols
INTRODUCTION

Vestibular schwannomas (sometimes referred to as acoustic neuromas) are tumors that
arise from the intracranial Schwann cells of cranial nerve VIII. These benign tumors represent
approximately 10% of all the primary brain tumors (Weber et al, 2003). The yearly incidence is
1 per 100,000 (Kaylie & McMenomey, 2005). They are generally slow growing tumors.
Nonetheless, vestibular schwannoma growth tends to result in the compression of surrounding
neurovascular structures. Patient symptoms may include hearing loss, tinnitus, dizziness/balance
issues, facial nerve paralysis and trigeminal nerve disorders.

Tumors are classified as Grade 1, Grade 2, Grade 3, Grade 4, or Grade 5 based on size:
Grade 1) small tumors measuring 1-10 mm
Grade 2) medium tumors measuring 11-20 mm
Grade 3) moderately-large tumors measuring 21-30 mm
Grade 4) large tumors measuring 31-40 mm
Grade 5) giant tumors those measuring more than 40 mm (Kanzaki et al., 2003).

Advances in modern imaging techniques have allowed for the detection of exceedingly
smaller tumors (as small as 2 mm). Tumors this small may have gone undiagnosed in past
decades (Swan, 2000). This early identification of tumors provides physicians three different
treatment options: watchful waiting, microsurgery and gamma knife radiosurgery.
The first option (watchful waiting) is most often utilized for smaller tumors or patients
who have been deemed poor surgical candidates (Kaylie & McMenomey, 2005). Elderly
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patients with deficient general health are an example of a poor surgical candidate. Conversely,
choosing the watchful waiting option for a patient who is a surgical candidate can lead to a future
poor surgical candidate (an older patient with a larger, more difficult to remove tumor)
(Sandooram et al., 2003). This makes watchful waiting a potentially hazardous option. Due to
this, microsurgery and gamma knife radiosurgery are chosen for most patients (Kaylie &
McMenomey, 2005).
The second option is microsurgery. The purpose of microsurgery is complete removal of
the tumor. Surgical resection of a vestibular schwannoma was first performed in 1894 by Sir
Charles Ballance. In Ballance’s time, morbidity and mortality rates were exceptionally high.
Advancements in surgical procedure include the adaptation of the surgical microscope by
William House in the early 1960’s (House, 1977) and the development of improved surgical
approaches. At present, there are three surgical approaches that are most widely used:
1) The enlarged translabyrinthine approach (ETLA), which allows the total removal of
the majority of the tumors independent of their size, with partial or no cerebellar
retraction.
2) The retrosigmoid approach (RSA), a routine operation in the field of neurosurgery for
the removal for the removal of various sized acoustic neuromas. Both the
translabyrinthine and retrosigmoid approaches are frequently used in cases where
tumors have a significant posterior fossa cisternal component (Kim et al., 2004).
3) The enlarged middle fossa approach (EMFA), performed for the removal of
intracranial tumor and/or with a maximal extrameatal extension of 0.5 cm (Sanna et
al., 2004). This approach is predominantly used for intracranial tumors with minimal
extension beyond the porus acusticus (Kim et al., 2004).
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Whereas morbidity (i.e. dizziness, hearing loss, and facial nerve paralysis) is still a concern when
performing microsurgery, mortality rates have significantly been reduced (House & Shelton,
1992). The morbidity rate (i.e. dizziness, hearing loss, and facial nerve paralysis) varies based
on the surgical approach. However, for the purpose of this study microsurgery will be assessed
as one group.
The third treatment option is gamma knife radiosurgery. Stereotactic radiation was
pioneered by Swedish neurosurgeon Dr. Lars Leksell in the 1950’s (Suh et al., 2004). Gamma
knife radiosurgery was not used to treat vestibular schwannomas until 1969 (Sanna et al., 2004).
Gamma knife radiosurgery is currently performed in a single session. This technique entails
collimated beams of radiation from a cobalt 60 source which target a defined intracranial
location. The goal of this treatment option is to induce avascular necrosis and collagen
deposition, making the tumor unable to grow (Kaylie & McMenomey, 2005).
Research has been performed trying to determine which therapy option has the best
outcome for patients. There are a multitude of ways to assess each treatment modality. These
past studies have been quality of life studies, symptom specific studies, and comparative studies.
However, balance outcome has been relatively poorly studied in comparison to hearing and
facial nerve function studies.
LITERATURE REVIEW

Quality of Life Studies
Studies on vestibular schwannoma treatment outcome have often relied on quality of life
tools such as the Glasgow Benefit Inventory (GBI) (Robinson et al., 1996) and the Short Form36 (SF36) (Ware and Sherbourne, 1992). Both of these tools are somewhat general, featuring
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questions such as “Do you feel better of worse about yourself?” or may have general questions
like “Are there more or fewer people who really care about you?”
The GBI was developed especially for patients who have had otorhinolaryngological
interventions (Robinson et al., 1996). The GBI is a validated questionnaire and allows for
comparisons to be made between interventions. Because of this, the questions on the GBI were
generated to measure a general perception of wellbeing rather than a particular symptom.
The SF36 is an outcome measure developed to be used as a tool to assess the health status
after medical and surgical treatments (da Cruz et al., 2000). SF36 was validated by
administering the questionnaire on both healthy people and those who have undergone medical
or surgical treatment in order to confirm that there is a divergence in scores. The disadvantage of
using this test is that it is a universal questionnaire for any medical or surgical treatment and that
it is not symptom specific.
A study conducted by da Cruz et al. (2000) used the SF36 to evaluate treatment outcomes
after vestibular schwannoma surgery. This study assessed 72 patients who had undergone
vestibular schwannoma excision 18 or greater months prior to the time of the investigation. The
results of the study were that patients who have surgical removal of vestibular schwannomas
have a reduced quality of life compared to matched peers in the general population. However,
this study did not focus on specific patient reported morbidities nor did the investigators compare
microsurgical with either of the other treatment options.
Another study performed by Nikolopoulos et al. (1998) used a questionnaire based on the
GBI to evaluate quality of life after acoustic neuroma (vestibular schwannoma) surgery. They
looked at 53 patients one to three years post-treatment. The researchers in this study concluded
that there is a possibility of a patient’s quality of life being negatively affected by having
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vestibular schwannoma surgery regardless of tumor size and therefore patients should be
thoroughly informed about the consequences of the operation. The focuses of this study were
issues such as financial status and occupation rather than specific surgical morbidities (i.e.
hearing loss or vestibular dysfunction).
One study that examined the post-treatment results of patients who had microsurgical
vestibular schwannoma removal using a general QOL questionnaire as well as a disease specific
questionnaire was performed by Irving et al. (1995). Researchers used both a general
questionnaire called the European Organization for Research into the Treatment of Cancer
(EORTC) core and a vestibular schwannoma disease specific module. The EORTC assesses
quality of life and physical condition using a 7-point scale ranging from very poor to excellent
(Smith et al., 1999). The added disease specific module included questions related to the
function of cranial nerves V, VII, and VIII. The 227 patients who took part in the survey had a
significant difference in subjective functional outcome between those whose tumors were less
than 1.5 cm in maximum diameter and those whose tumors were greater than 1.5 cm in
maximum diameter. Patients who had smaller (less that 1.5 cm) tumors had a significantly better
outcome. However, there was not a significant difference between those with tumors 1.5 to 2.5
cm and those with tumors larger than 2.5 cm. The Irving et al. (1995) study did not reveal any
subjective functional differences on the basis of the age of the patient. These authors found that
the patients’ overall quality of life following vestibular schwannoma excision was excellent. The
distribution of patients who had a poor functional outcome was equal across the tumor size
range. This study did give more detailed insight to patients and physicians as to what the
surgical outcome may be for patients. However, this study did not access the outcome of either
of the alternative treatment options.
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These studies provided general information for an intervention not based on specific
morbidities of patients. However, a more focused evaluation of treatment outcomes would most
times be preferable. For vestibular schwannomas, these treatment outcomes involve hearing,
tinnitus, facial nerve function, as well as balance function.

Symptom Specific Studies
Wiegand and Fickel (1989) completed a large symptom specific postal questionnaire on
541 members of the American Neuroma Association who underwent surgical tumor removal.
This retrospective study looked at the above listed subjective treatment outcomes (hearing loss,
tinnitus, facial nerve function, and balance function) and other nonotologic issues: eye-related
issues, depression, anxiety, headache, sleep disturbance, patient independence, self-image,
fatigue, dental problems, speech or swallowing difficulty, and sexual dysfunction. The results of
the balance section of the questionnaire revealed that 90% of these patients reported
disequilibrium. Nevertheless, only 8% of patient responded that they felt severely handicapped
by the disequilibrium. 30% of respondents with dizziness indicated that dizziness was improved
or cured by surgery. 1% of patients believed their dizziness worsened after surgery. The
patients also listed conditions which seemed to make dizziness worsen including fatigue,
darkened surroundings, and change in position. This study did not include any gamma knife
patients.
Another study that focused on specific post-treatment symptoms was done by Ryzenman
et al. (2004). This was a postal questionnaire of 1940 members of the Acoustic Neuroma
Association. This questionnaire asked patients to list the “most difficult aspect of the AN
(acoustic neuroma) experience.” The researchers analyzed the responses by considering the
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patient’s tumor size, surgical approach, age, and sex. Men reported hearing loss, balance
problems, perioperative surgical experience, and eye and facial weakness (in that order) as being
most problematic. Women had the most trouble with hearing loss, facial weakness, eye
problems, and headaches respectively. Patients (both men and women) who had large tumors,
were younger in age, and who underwent the retrosigmoid approach reported facial weakness
more frequently. Patients over the age of 75 years tended to report more balance dysfunction.
Patients who had small tumors frequently reported headaches and balance problems. This study
provided important information regarding surgical treatment outcome.
Darrouzet et al. (2004) researched the short and intermediate postoperative complications
that patient experience following vestibular schwannoma surgery. The authors did a chart
review of 400 patients. The vestibular results section of the study revealed that acute vertigo was
a common complaint (45.5% of patients) during the period immediately following surgery.
78.2% of patients revealed that unsteadiness was “troublesome.” 30% of patients were still
experiencing vestibular disturbances one year post-treatment. The researchers involved in the
study did not review the charts of gamma knife or watchful waiting patients.
Gjurić et al. (2001) performed a retrospective case review of 735 patients who had
surgical removal of vestibular schwannomas. Researchers analyzed facial nerve function,
hearing preservation, and the percentage of the tumor able to be removed for each patient. This
large study provided valuable information regarding surgical outcome. This study, as well as
past studies, omitted vestibular status as part of vestibular schwannoma treatment outcome
reporting.
Several studies have also used validated questionnaires as a way to analyze specific
effects of vestibular schwannoma treatment on patients. Humphriss et al. (2003) used the
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Dizziness Handicap Inventory to assess the change in vestibular function of 100 consecutive
patients undergoing tumor excision. The authors found that for the majority of patients there
were no change in DHI scores after excision. In those patients whose scores did worsen, there
were significant drops between the preoperative time and the three month postoperative time
period and then scores did not continue to decline after three months. Researchers have also
studied the Tinnitus Handicap Inventory (Baguley et at., 2005) and Hearing Handicap Inventory
(Humphriss et al., 2004) scores of patients who have undergone surgical removal of vestibular
schwannomas. The foregoing studies did not administer these questionnaires to gamma knife
patients.
Looking at past studies it can be noted that previous research focuses primarily on
microsurgical treatment of vestibular schwannomas. One study done by Wackym et al. (2004)
did examine the outcome of gamma knife radiosurgery when treating acoustic neuromas
(vestibular schwannomas). The study was a prospective assessment of 33 patients. Researchers
looked at tumor control, changes auditory threshold and speech discrimination, tinnitus, facial
nerve function, trigeminal nerve function and balance function. Vestibular function was assessed
using bithermal caloric testing. After gamma knife radiosurgery 17 (71%) of the 24 patients
tested experienced some disequilibrium. New onset dizziness was seen in eight patients. One
patient had dizziness prior to treatment which resolved by the 12 month follow-up visit. This
study did not administer any subjective patient questionnaires.

Comparative Studies
Seldom have researchers compared the outcomes of the methods of treatment
(Nikolopoulos & O’Donoghue, 2002). One without consideration of balance was the one done
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by Shirato et al. (1999). The two treatment options compared were gamma knife radiosurgery
and watchful waiting. The study group consisted of 27 patients. The researcher involved in this
study examined tumor growth rate and hearing levels. The results of the study revealed the
tumor control rate was better for the gamma knife study group compared to the watchful waiting
group. The two groups had similar hearing deterioration rates. There was no consideration of
balance.
A study done by Myrseth et al. (2005) evaluated treatment outcome in terms of facial
nerve function (House-Brackman Grade 1-2), hearing, complication rates and general quality of
life. The researchers in this study used both the SF36 and the GBI to assess the quality of life for
both microsurgical and gamma knife patients. The results of this retrospective study showed that
patients are somewhat happier with gamma knife than with microsurgery. Nonetheless, these
authors did not include specific questions regarding vestibular function in their assessment.
With the wealth of research on the subject of vestibular schwannoma outcome,
physicians can better counsel and recommend appropriate management strategies. However,
research has shown that even when patients are “educated” about all three vestibular
schwannoma treatment options, physicians can be biased and will convey this bias to patients
(Pogodzinski et al., 2004). Therefore, it is crucial that physicians have research data to reference
when discussing patient options. Imbalance associated with each option has not been extensively
studied. Thus physicians and patients are unable to include the level of imbalance post-treatment
into their decision making process.
The aim of this study was to evaluate short- and long-term balance function after
microsurgical tumor removal and gamma knife radiosurgery.
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METHODS
This study was approved by the Human Studies Committee of Washington University
School of Medicine.

PARTICIPANTS
The study was an analysis of a retrospective postal questionnaire. This study was
performed on a group of patients who had been treated at Washington University School of
Medicine for vestibular schwannomas. The study group was collected from a database of
consecutive series of 60 patients whose complete medical record was available at Washington
University School of Medicine. The patients had undergone either microsurgical tumor removal
(n = 29) or gamma knife radiosurgery (n = 31). Patients were mailed the questionnaires and
asked to return them in a prepaid envelope. Of the mailed questionnaires, 34 were returned.
Three patients who returned questionnaires were excluded because they underwent both
microsurgical tumor excision and gamma knife radiosurgery. The remaining 31 patients are the
subject of this report.

MATERIALS
Each questionnaire packet included an unvalidated subjective questionnaire regarding the
patient’s perceived balance status and overall state of health as well as a copy of a validated (the
Dizziness Handicap Inventory) questionnaire evaluating balance function (Appendix I).
The unvalidated portion of the questionnaire included both closed and open questions.
The closed questions required patients to select an answer from a given list of possible choices.

11

Nichols
The closed set choices were scored as follows: poor (score=1), fair (score=2), average (score=3),
good (score=4), and excellent (score=5). The open questions allowed patients to answer
questions in their own words.
The validated portion of the questionnaire was the Dizziness Handicap Inventory (DHI).
The DHI consists of 25 questions divided into three categories: functional, emotional, and
physical. There are three response options for each question “yes,” “no,” and “sometimes.” The
scoring for all of the questions is as follows: A “yes” response is scored 4 points, a “no” response
is scored 0 points, and a “sometimes” response is scored 2 points. “Thus, possible scores on the
total subscale range from 0, suggesting no handicap, to 100, indicating significant self-perceived
handicap” (Jacobson et al., 1990).
The DHI questionnaire was modeled after the Hearing Handicap Inventory for the
Elderly (Jacobson et al., 1990). Jacobson et al. (1990) states, “The 25-item Dizziness Handicap
Inventory (DHI) was developed to evaluate the self-perceived handicapping effects imposed by
vestibular system disease.”
Developers proposed that the DHI would fill a void in conventional diagnostic tests,
which were not adequate for evaluating the handicapping effects of vestibular disorders.
Jacobson et al. (1990) states, “Dizziness is one of the few disease symptoms that is capable of
causing patients to modify their lives even in its absence. Thus, it is a common clinical
observation that intermittent dizziness often effects changes in a patient’s daily activities even
during time of remission. For example, individuals may restrict their driving habits or social
activities in fear of a dizziness attack.” Conversely, results of the DHI could also reveal a patient
population that has constant dizziness and do not consider themselves to be handicapped by the
condition (Jacobson et al., 1990). Because of the possible inconsistencies in objective and
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subjective vestibular disorder measurements, conducting a patient perceived measure of
handicap is an important part of understanding and treating a patient.

STATISTICAL TECHNIQUES
Statistical analysis of the data was performed using either T-tests or the McNemar test via
the following website: http://vassun.vassar.edu/~lowry/VassarStats.html.

RESULTS
GROUP COMPOSITION
A complete set of useable questionnaires was returned by 31 (response rate of 51.7%) of
the 60 patients. Of the 31 questionnaires returned, 16 (51.6%) were from the microsurgery group
and 15 (48.4%) were from the gamma knife group. For the patients who returned questionnaires,
medical charts were reviewed to obtain additional information regarding sex, age at time of
treatment, time since treatment, and size of tumor.

DEMOGRAPHICS
For the microsurgical group there were ten (62.5 %) males and six (37.5 %) females. The
age of the microsurgical group ranged from 31 to 67, with a mean age of 52 years (SD= 9.6).
The median age was 54 years. Figure 1 below displays the microsurgical patient age
distribution.
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Figure 1

Number of Patients

Female
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1
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71-80

>80

Microsugical Patient Age in Years

Figure 1. Age distribution of microsurgical respondents by gender. The white bar represents female
respondents in the microsurgical study group. The black bar represents male respondents in the
microsurgical study group.

For the gamma knife group there were ten (66.7 %) males and five (33.3 %) females.
The age of the gamma knife group ranged from 18 to 77, with a mean age of 59 years (SD=
14.5.). The median age was 62 years. Figure 2 below displays the gamma knife patient age
distribution.
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Figure 2
Female
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Figure 2. Age distribution of gamma knife respondents by gender. The white bar represents female respondents in
the gamma knife study group. The black bar represents male respondents in the gamma knife study group.

A t-test revealed no significant difference between the ages of the microsurgery and
gamma knife study groups (P = .089).

CLINICAL CONDITIONS
For the microsurgical study group the tumors ranged from 0.6 to 4.0 cm, with a mean size
of 1.9 cm (SD = .93). The mean tumor size was Grade 2. The median size of microsurgical
study group’s tumors was 1.7 cm. For the gamma knife study group the tumors ranged from 1.1
to 2.6cm, with a mean size of 1.5 cm (SD = .46). The mean tumor size was Grade 3. The
median size of gamma knife study group’s tumors was 1.5 cm. A t-test revealed no significant
difference between the tumor size of the study groups (P = .137). Figure 3 below represents the
mean size of tumors in each study group.
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Figure 3
Size of Tumor in Centimeters

Microsurgery
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3
2.5
2
1.5
1
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Type of Treatment

Figure 3. Mean diameter of tumor in each study group. The black bar represents the microsurgery study
group. The white bar represents the gamma knife study group. The error bars represent the standard
deviation from the mean.

Patients from the microsurgical group were a mean of 1.6 years post-treatment (range, 0.5
to 3.5 years; SD=.88). The median was 1.5 years. Likewise, patients from the gamma knife
group were also a mean of 1.6 years post-treatment (range, 0.5 to 3 years; SD = .99). The
median was 1.75 years. A t-test revealed no significant difference in the time since treatment
between the microsurgical and gamma knife study groups (P = .827). Figure 4 below is a
graphic representation of the mean number of years for each study group.
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Figure 4

Years Since Treatment

Microsurgery

Gamma Knife
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2
1.5
1
0.5
0
Type of Treatment

Figure 5. Mean number of years since patient underwent treatment modality. The black bar represents
patients in the microsurgery study group. The white bar represents patients in the gamma knife study
group. The error bars represent the standard deviation from the mean.

GENERAL HEALTH STATUS
For the microsurgical group patient perception of overall health now had responses in all
possible categories (Poor, Fair, Average, Good, and Excellent). The mean score for this group
was 3.75 (SD=1.13). The gamma knife group had responses in four of the five possible
categories (Fair, Average, Good, and Excellent). The mean score for this group was 3.87
(SD=.99). A t-test of the data revealed no significant difference between groups for the status
overall health now. This suggests patients in both groups generally feel the same about their
current health.
For the microsurgical group patient perception of overall health prior to excision again
had responses in all possible categories. The mean score for this group was 3.69 (SD=1.35).
The gamma knife group had responses in all of the five possible categories. The mean score for
this group was 3.67 (SD=1.23). A t-test of the data revealed no significant difference between
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groups for the overall status of health prior to treatment. This suggests patients in both groups
generally feel the same about their health before they underwent treatment.
Next, patient opinion of how their overall health will be in five years was assessed. This
section of the questionnaire was an open question. For the microsurgical group 31.25% (n=5) of
patients felt that in five years their health would be “Excellent.” 37.5% (n=6) of microsurgical
patients felt that their health would be “Good.” 6.25% (n=1) of patients in this group responded
their health would be “Average” in five years. 6.25% (n=1) of patients responded that they
believe their health would be “Fair” in five years. 18.75% (n=3) of the microsurgical study
group had hope for improvement in overall health status.
When the gamma knife study group was evaluated on the bases of perceived overall
health in five years, 20% (n=3) of patients felt that in five years their health would be
“Excellent.” 26.7% (n=4) of patients felt that their health would be “Good.” 13.3% (n=2) of
patients in this group responded their health would be “Average” in five years. 6.7% (n=1) of
patients responded that they believe their health would be “Fair” in five years. 6.7% (n=1)
responded that they thought their health would be “Poor” in five years. 6.7% (n=1) of the
gamma knife study group had hope for improvement in their overall health status. 6.7% (n=1) of
the gamma knife study group replied they think their overall health status will be “The same to
worse.” 13.3% (n=2) of gamma knife patients responded they were “Unsure” of what their
overall health status would be in five years.
12 (75%) patients in the microsurgical group reported having dizziness prior to treatment.
Four (25%) patients in this same group reported they did not have any dizziness prior to tumor
excision. Nine (60%) patients in the gamma knife study group reported having dizziness prior to
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treatment. Six (40%) patients in the gamma knife group reported they did not have any dizziness
prior to radiosurgery.
Given these results, McNemar chi-square test was performed to analyze the relationship
of pretreatment symptoms to post-treatment symptoms (if you have dizziness before treatment
will you have dizziness afterwards). Table 1 and Table 2 below are the graphic representation of
this analysis.
Table 1

Post-treatment
Dizziness

Microsurgery
Pretreatment
Dizziness

Yes
No
Sum

Yes
9
3
12

No
3
1
4

Sum
12
4
16

Table 1. McNemar chi-square test

For the microsurgical study group there was no significant difference (P=1.3) identified.
These results suggest that for the given data there is no relationship between having dizziness
before treatment and having dizziness afterwards due to microsurgery.

Table 2

Post-treatment
Dizziness

Gamma Knife
Pretreatment
Dizziness

Yes
No
Sum

Yes
9
1
10

Table 2. McNemar chi-square test
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No
1
4
5

Sum
10
5
15
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Similarly, in the gamma knife group there was no significant difference (P=1.5) detected.
Again, these results suggest that for the given data there is no relationship between having
dizziness before treatment and having dizziness afterwards due to gamma knife treatment.
Patients were also asked to answer a question regarding dizziness in spells prior to their
treatment. In the group who underwent microsurgical tumor excision there were six (37.5%)
“Yes” responses and ten (62.5%) “No” responses. The results for patients who underwent
gamma knife radiosurgery revealed four (26.7%) “Yes” responses, ten (66.7%) “No” responses,
and one (6.7%) individual who did not answer the question.
Then the study groups were asked to answer a question regarding dizziness in spells after
treatment. In the microsurgical group of respondents there were five (31.25%) “Yes” responses
and eleven (68.75%) “No” responses. The results for patients who underwent gamma knife
radiosurgery revealed six (40%) “Yes” responses, eight (53.3%) “No” responses, and one (6.7%)
individual who did not answer the question.
Patients were also asked about dizziness or imbalance limiting their daily activities prior
to treatment. The results from microsurgery study group showed seven (43.75%) patients who
responded “Yes”, eight (50%) who responded “No”, and one (6.25%) who did not respond. The
gamma knife patients had five (33.3%) “Yes” responses, nine (60%) “No” responses, and one
(6.7%) who patient who did not answer.
Next patients where asked “Do you have dizziness or imbalance now that limits your
daily activities?” The microsurgery study group had six (37.5%) patients who responded “Yes”
and ten (62.5%) who responded “No.” The gamma knife patients had seven (47%) “Yes”
responses and eight (53%) “No” responses. Many patients in both groups also noted that
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climbing stairs, walking, and maneuvering in darkness are problematic. Patients stated they try
to avoid or require help when in these situations.
Another section of the questionnaire that was an open question was “Would you choose
the same treatment again?” For the microsurgery study group 12 (75%) answered “Yes”, one
(6.25%) patient answered “No”, two (12.5%) answered “Not sure” and one (6.25%) patient
responded “No comment.” For the gamma knife study group 12 (80%) answered “Yes” when
asked if they would repeat the same treatment again, 1 (6.7%) patient answered “No”, one
(6.7%) patient answered “Not sure”, and one patient (6.7%) responded “Maybe not”.

DHI RESULTS
The subsequently an analysis was done on the DHI score of both the microsurgery and
gamma knife radiosurgery study groups. The scores were divided into the three domains:
functional, emotional, or physical. In none of the three domains were any significant differences
found between the two study groups. These results suggest that microsurgical and gamma knife
patients do not have a divergence in their perceived dizziness handicap post-treatment. Figure 5
below, represents these data.
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Figure 5
3

Microsurgery
Gamma Knife
2.5

Average Score

2

1.5

1

0.5

0
Functional

Emotional

Physical

Figure 5. Average DHI functional, emotional, & physical scores of microsurgical and gamma knife
patients. The black bar represents the microsurgery study group. The white bar represents the gamma knife
study group. The error bars represent the standard deviation from the mean.

In the DHI portion of the questionnaire there were certain questions that showed patterns
among responses. No one in either group answered “yes” to questions #1 (Does looking up
increase your problem?), 7 (Because of your problem, do you have difficulty reading?), or 18
(Because of your problem, is it difficult for you to concentrate?). For question #22 (Has your
problem placed stress on your relationships with members of your family or friends?) no one in
the gamma knife group answered “yes.” No one in the microsurgery group answered yes to
question #5 (Because of your problem, do you have difficulty getting into or out of bed?).
Respondents in both groups frequently answered “yes” to questions #11 (Do quick movements
of your head increase your problem?) and #12 (Because of your problem, do you avoid
heights?). Questions #20 (Because of your problem, are you afraid to stay home alone?) and #21
22
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(Because of your problem, do you feel handicapped?) only one had “yes” response from the
gamma knife group.

DISCUSSION
Research on the subject of vestibular schwannoma outcome can better help physicians
counsel and recommend appropriate management strategies. It is essential that physicians have
this research data in order to inform patients about the vestibular outcome associated with each
option. Studies like this one allow physicians and patients to be able to include the level of
imbalance post-treatment into their decision making process.
The two groups involved in this study showed no statistical difference in their mean age.
However, Figures 1 and 2 show a difference in the shape of the overall age distribution. The
gamma knife study group (Figure 2) was composed of patients who were both younger and also
older than anyone in the microsurgical study group (Figure 1). The microsurgery patients had
slightly larger tumors than the gamma knife patients (Figure 3). However, the difference in size
between groups was small and not significantly different. The general health between the
microsurgical and gamma knife study groups was equal. The DHI scores of the two study
groups were also equal. As a result, the two groups can still be compared.
Wiegand and Fickel (1989) studied patients who had undergone surgical tumor removal.
These researchers found that 30% of the microsurgical patients involved in their study had
dizziness that was “cured” or improved by surgery. This current study had two study groups
(microsurgery and gamma knife radiosurgery). For the microsurgery group, three (25%) of the
twelve patients who had dizziness prior to treatment did not have dizziness post-treatment (Table
1). This is similar to the 30% found in the Wiegand and Fickel (1989) study. For the gamma
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knife group, one (10%) of the 10 patients who had dizziness prior to treatment did not have
dizziness post-treatment (Table 2). This suggests that perhaps gamma knife is not as therapeutic
as microsurgery in terms of dizziness. This could be due to the individual goals of each
treatment option. The goal of microsurgery is total tumor removal. The goal of gamma knife
radiosurgery is to inhibit further tumor growth. Gamma knife patients still have a tumor present.
Therefore, in cases where the patient’s primary concern is “curing” dizziness, physicians and
patients may want to choose microsurgery.
This study showed no relationship between having not having dizziness prior to treatment
and having dizziness after treatment in either study group. This means that using this research
data, physicians cannot indicate to their patients whether microsurgery or gamma knife
radiosurgery will “cure” or exacerbate dizziness.
In summary, this study has shown that patients who undergone both microsurgical tumor
removal and those who have undergone gamma knife radiosurgery for vestibular schwannoma
have dizziness is a subsequent treatment morbidity. The investigation also shows that the two
groups studied seem to have equal vestibular dysfunction. Neither group has more imbalance
and nor does either group feels more handicapped by their post-treatment condition.
LIMITATIONS
One limitation of this study was the use of a retrospective questionnaire. This required
patients to recall pretreatment vestibular function. In some cases this was more than three years
prior to the actual administering of the questionnaire. Another weakness of the study was the
setup of the overall health status portion of the questionnaire. This was evident because some of
the respondents did not complete all items. Another major limitation was the small sample size
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(n=31 respondents). The sample size makes it difficult to generalize the results to the entire
microsurgical and gamma knife patient populations.
Future studies should have larger sample sizes. Also studies should be prospective, so
patients’ vestibular status can be well established before and after treatment. Researchers should
also do both subjective (i.e. the DHI) and objective testing (i.e. calorics, rotary chair, head-trust
sign, and posturography) to evaluate the vestibular function of patients.
Despite these limitations, this study does have clinical applications. Physicians can use
the results to counsel patients on the outcomes of past patients and possibility what they can
expect. The results of the study suggest patients who have vestibular schwannomas will have
dizziness and imbalance following microsurgery and gamma knife radiosurgery.
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APPENDIX
Appendix I
General Questions:
(1) Please mark the box that best describes your overall level of health now.

□Poor □Fair

□Average □Good

□Excellent

(2) Did you have dizziness or imbalance prior to your treatment?
Was it in spells? Did it limit your activity at any point?

(3) Have you had dizziness or imbalance at any time following your treatment?

Was it in spells? Did it limit your activity at any point?

(4) Do you have dizziness or imbalance now that limits your daily activities? If so, which
activities does it limit (eg driving, walking without assistance)?

(5) Would you choose the same treatment again?

(6) Please mark the box that best describes your overall level of health prior to treatment.

□Poor □Fair

□Average □Good

□Excellent

(7) How do you expect your health to be in 5 years from now?
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Dizziness Handicap Inventory:
The purpose of these questions is to identify difficulties that you may be experiencing because of
your dizziness. Please mark "yes", "no", or "sometimes" for each question. Answer each question
as it pertains to your dizziness or balance problem since vestibular schwannoma treatment.
(1) Does looking up increase your problem?

□Yes

□No

□Sometimes

(2) Because of your problem, do you feel frustrated?

□Yes

□No

□Sometimes

(3) Because of your problem, do you restrict your travel for business or recreation?

□Yes

□No

□Sometimes

(4) Does walking down the aisle of a supermarket increase your problem?

□Yes

□No

□Sometimes

(5) Because of your problem, do you have difficulty getting into or out of bed?

□Yes

□No

□Sometimes

(6) Does your problem significantly restrict your participation in social activities such as going out
to dinner, going to movies, dancing, or to parties?

□Yes

□No

□Sometimes

(7) Because of your problem, do you have difficulty reading?

□Yes

□No

□Sometimes

(8) Does performing more ambitious activities like sports, dancing, household chores such as
sweeping or putting dishes away increase your problem?

□Yes

□No

□Sometimes

(9) Because of your problem, are you afraid to leave your home without having some one
accompany you?

□Yes

□No

□Sometimes

(10) Because of your problem, have you been embarrassed in front of others?

□Yes

□No

□Sometimes

(11) Do quick movements of your head increase your problem?

□Yes

□No
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(12) Because of your problem, do you avoid heights?

□Yes

□No

□Sometimes

(13) Does turning over in bed increase your problem?

□Yes

□No

□Sometimes

(14) Because of your problem, is it difficult for you to do strenuous housework or yardwork?

□Yes

□No

□Sometimes

(15) Because of your problem, are you afraid people may think you are intoxicated?

□Yes

□No

□Sometimes

(16) Because of your problem, is it difficult for you to walk by yourself?

□Yes

□No

□Sometimes

(17) Does walking down a sidewalk increase your problem?

□Yes

□No

□Sometimes

(18) Because of your problem, is it difficult for you to concentrate?

□Yes

□No

□Sometimes

(19) Because of your problem, is it difficult for you to walk around your house in the dark?

□Yes

□No

□Sometimes

(20) Because of your problem, are you afraid to stay home alone?

□Yes

□No

□Sometimes

(21) Because of your problem, do you feel handicapped?

□Yes

□No

□Sometimes

(22) Has your problem placed stress on your relationships with members of your family or friends?

□Yes

□No

□Sometimes

(23) Because of your problem, are you depressed?

□Yes

□No

□Sometimes

(24) Does your problem interfere with your job or household responsibilities?

□Yes

□No

□Sometimes

(25) Does bending over increase your problem?

□Yes

□No
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